Sec. 303. Reporting requirements
182 words·~1 min read·
/bill/115/hr/7339/ih/section-303A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Board shall require each manufacturer of a prescription drug or medical device that is sold in the United States to submit to the Board on a periodic basis, at a level of specificity determined by the Board to be necessary to make a determination under section 304, the following information with respect to the reporting period: Each type of prescription drug and medical device that is sold by the manufacturer or an affiliate of the manufacturer— in the United States; or in a country that is a member of the Organization for Economic Co-operation and Development.
The price charged by the manufacturer and the affiliate for the prescription drug or medical device in the United States and in any such country, as applicable. The costs of the manufacturer and the affiliate to produce and market the prescription drug or medical device for sale in the United States and in any such country, as applicable. The Director of the Congressional Budget Office shall submit an annual report to the Board on trends in the prices charged for prescription drugs and medical devices.